SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-015355
Filing Date
2016-11-21
Accepted
2016-11-21 16:57:56
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 376584
2 ex10-2.htm EX-10.2 322956
3 ex10-3.htm EX-10.3 181819
4 ex10-4.htm EX-10.4 124968
5 ex10-5.htm EX-10.5 166243
6 ex10-6.htm EX-10.6 103956
7 ex10-7.htm EX-10.7 104036
8 ex31-1.htm EX-31.1 8291
9 ex31-2.htm EX-31.2 8522
10 ex32-1.htm EX-32.1 5538
11 ex32-2.htm EX-32.2 5141
  Complete submission text file 0001493152-16-015355.txt   3180355

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE obmp-20160930.xml EX-101.INS 286639
13 XBRL SCHEMA FILE obmp-20160930.xsd EX-101.SCH 30260
14 XBRL CALCULATION FILE obmp-20160930_cal.xml EX-101.CAL 36766
15 XBRL DEFINITION FILE obmp-20160930_def.xml EX-101.DEF 98604
16 XBRL LABEL FILE obmp-20160930_lab.xml EX-101.LAB 222627
17 XBRL PRESENTATION FILE obmp-20160930_pre.xml EX-101.PRE 163367
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 162010875
SIC: 2834 Pharmaceutical Preparations